|
Name |
2-Chloro-1,7-dihydroxy-3,9-dimethoxy-1-methylbenzo[c]chromene-4,6-dione
|
| Molecular Formula | C16H13ClO7 | |
| IUPAC Name* |
2-chloro-1,7-dihydroxy-3,9-dimethoxy-1-methylbenzo[c]chromene-4,6-dione
|
|
| SMILES |
CC1(C2=C(C(=O)C(=C1Cl)OC)OC(=O)C3=C2C=C(C=C3O)OC)O
|
|
| InChI |
InChI=1S/C16H13ClO7/c1-16(21)10-7-4-6(22-2)5-8(18)9(7)15(20)24-12(10)11(19)13(23-3)14(16)17/h4-5,18,21H,1-3H3
|
|
| InChIKey |
UMKWAHOXPWRVRW-UHFFFAOYSA-N
|
|
| Synonyms |
TMC-264; 2-chloro-1,7-dihydroxy-3,9-dimethoxy-1-methylbenzo[c]chromene-4,6-dione; 2-chloro-4,6-dihydro-1,7-dihydroxy-3,9-dimethoxy-1-methyl-1h-dibenzo[b,d]pyran-4,6-dione
|
|
| CAS | NA | |
| PubChem CID | 24857889 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 352.72 | ALogp: | 1.7 |
| HBD: | 2 | HBA: | 7 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 102.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 24 | QED Weighted: | 0.855 |
| Caco-2 Permeability: | -4.847 | MDCK Permeability: | 0.00003290 |
| Pgp-inhibitor: | 0.265 | Pgp-substrate: | 0.005 |
| Human Intestinal Absorption (HIA): | 0.042 | 20% Bioavailability (F20%): | 0.004 |
| 30% Bioavailability (F30%): | 0.069 |
| Blood-Brain-Barrier Penetration (BBB): | 0.064 | Plasma Protein Binding (PPB): | 87.05% |
| Volume Distribution (VD): | 0.879 | Fu: | 13.26% |
| CYP1A2-inhibitor: | 0.984 | CYP1A2-substrate: | 0.931 |
| CYP2C19-inhibitor: | 0.632 | CYP2C19-substrate: | 0.295 |
| CYP2C9-inhibitor: | 0.702 | CYP2C9-substrate: | 0.524 |
| CYP2D6-inhibitor: | 0.503 | CYP2D6-substrate: | 0.199 |
| CYP3A4-inhibitor: | 0.729 | CYP3A4-substrate: | 0.216 |
| Clearance (CL): | 1.949 | Half-life (T1/2): | 0.597 |
| hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.858 |
| Drug-inuced Liver Injury (DILI): | 0.958 | AMES Toxicity: | 0.327 |
| Rat Oral Acute Toxicity: | 0.319 | Maximum Recommended Daily Dose: | 0.457 |
| Skin Sensitization: | 0.576 | Carcinogencity: | 0.044 |
| Eye Corrosion: | 0.008 | Eye Irritation: | 0.033 |
| Respiratory Toxicity: | 0.892 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003470 | ![]() |
0.829 | D06GCK | ![]() |
0.317 | ||
| ENC003468 | ![]() |
0.786 | D0G4KG | ![]() |
0.286 | ||
| ENC003115 | ![]() |
0.703 | D0C1SF | ![]() |
0.277 | ||
| ENC003829 | ![]() |
0.662 | D0K8KX | ![]() |
0.253 | ||
| ENC002938 | ![]() |
0.616 | D02PMO | ![]() |
0.240 | ||
| ENC003472 | ![]() |
0.537 | D0R6RC | ![]() |
0.240 | ||
| ENC005093 | ![]() |
0.518 | D0Z4XW | ![]() |
0.238 | ||
| ENC002134 | ![]() |
0.512 | D04AIT | ![]() |
0.232 | ||
| ENC002633 | ![]() |
0.506 | D0W7JZ | ![]() |
0.230 | ||
| ENC001631 | ![]() |
0.494 | D02GAC | ![]() |
0.228 | ||